When MCF-7-C3 and T47D breast cancer cells were medicated with genistein, the cancerous inhibitor of protein phosphatase 2A (CIP2A), a human oncoprotein, was dysregulated, leading to the hypothesis that CIP2A was a genistein target [43] in causing growth inhibition and apoptosis. The gene discussed is CIP2A; the disease is breast cancer.